1 results  1 of 1 

1 The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
Emma L. Barber, Emese Zsiros, John R. Lurain, Alfred Rademaker, Julian C. Schink, Nikki L. Neubauer
J Gynecol Oncol.2013;24(3):258-264.   Published online 2013 July 4     DOI: http://dx.doi.org/10.3802/jgo.2013.24.3.258
      

 1 of 1